Development of a Nomogram Model for Predicting Anxiety Risk in Patients with Hyperhidrosis: A Study Involving 234 Patients

注册号:

Registration number:

ITMCTR2025000998

最近更新日期:

Date of Last Refreshed on:

2025-05-16

注册时间:

Date of Registration:

2025-05-16

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

多汗症人群中患有焦虑状态的回顾性研究方案

Public title:

Development of a Nomogram Model for Predicting Anxiety Risk in Patients with Hyperhidrosis: A Study Involving 234 Patients

注册题目简写:

多汗症人群中患有焦虑状态的回顾性研究方案

English Acronym:

Development of a Nomogram Model for Predicting Anxiety Risk in Patients with Hyperhidrosis: A Study Involving 234 Patients

研究课题的正式科学名称:

多汗症人群中患有焦虑状态的回顾性研究方案

Scientific title:

Development of a Nomogram Model for Predicting Anxiety Risk in Patients with Hyperhidrosis: A Study Involving 234 Patients

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

温浩

研究负责人:

陈欣燕

Applicant:

Hao Wen

Study leader:

Xinyan Chen

申请注册联系人电话:

Applicant telephone:

+86 151 7060 8120

研究负责人电话:

Study leader's telephone:

+86 13539984767

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1121244251@qq.com

研究负责人电子邮件:

Study leader's E-mail:

chenxinyancxy@gzucm.edu.cn

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

广东省广州市白云区广州中医药大学三元里校区

研究负责人通讯地址:

广东省广州市越秀区大德路广东省中医院治未病中心

Applicant address:

Sanyuanli Campus Guangzhou University of Traditional Chinese Medicine Baiyun District Guangzhou City Guangdong Province China

Study leader's address:

none

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广东省广州市越秀区大德路111号

Applicant's institution:

No.111 Dade Road Yuexiu District Guangzhou City Guangdong Province China

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

ZE2023-327-01

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

广东省中医院伦理委员会

Name of the ethic committee:

Ethics Committee of Guangdong Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2023/9/12 0:00:00

伦理委员会联系人:

李晓彦

Contact Name of the ethic committee:

Li Xiao Yan

伦理委员会联系地址:

广东省广州市越秀区大德路111号

Contact Address of the ethic committee:

No.111 Dade Road Yuexiu District Guangzhou City Guangdong Province China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 20 8188 7233

伦理委员会联系人邮箱:

Contact email of the ethic committee:

llbgs@gzucm.edu.cn

研究实施负责(组长)单位:

广东省中医院

Primary sponsor:

Guangdong Hospital of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

广东省广州市越秀区大德路111号

Primary sponsor's address:

No.111 Dade Road Yuexiu District Guangzhou City Guangdong Province China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guang Dong

City:

单位(医院):

广东省中医院

具体地址:

广东省广州市越秀区大德路111号

Institution
hospital:

Guangdong Hospital of Traditional Chinese Medicine

Address:

No.111 Dade Road Yuexiu District Guangzhou City Guangdong Province China

经费或物资来源:

广东省中医院

Source(s) of funding:

Guangdong Hospital of Traditional Chinese Medicine

研究疾病:

多汗症

研究疾病代码:

Target disease:

hyperhidrosis

Target disease code:

研究类型:

Study type:

观察性研究

Observational study

研究设计:

Study design:

横断面

Cross-sectional

研究所处阶段:

Study phase:

回顾性研究

Retrospective study

研究目的:

探讨多汗症人群与焦虑状态之间关系

Objectives of Study:

Exploring the relationship between hyperhidrosis populations and anxiety states

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1.2020年6月-2023年8月,广东省中医院健康调养门诊患者。 2.符合多汗症诊断成人患者: ①多汗症:无明显诱因的多汗症状持续至少6个月,以及以下特征中的至少两种: (1)双侧对称的;(2)干扰正常活动;(3)每周至少发生一次; (4)家族史;(5)睡眠时不发作。 ②焦虑:(1)符合焦虑障碍的诊断标准;(2)以原发性焦虑症状为主并符合下面两点要求:a经常对某一固定内容或无确定的事物持续一段时间产生恐惧或担忧;b患者焦虑状态发作时伴有运动型不安和自主神经功能紊乱;(3)患者自觉难以承受又反复陷入自我感觉痛苦的状态;(4)符合上述标准至少已6个月;(5)排除因使用成瘾药物、或者戒断某些药物所导致的焦虑;排除其他精神疾患所继发的焦虑状态;排除因脑中风、心脑血管疾患等躯体疾病引发的焦虑。

Inclusion criteria

1. Patients from the Health Preservation Outpatient Clinic at the Guangdong Provincial Hospital of Traditional Chinese Medicine from June 2020 to August 2023. 2. Adult patients who meet the diagnostic criteria for hyperhidrosis: Hyperhidrosis: Excessive sweating without any obvious trigger persisting for at least 6 months Additionally at least two of the following characteristics are met: (1) Bilateral and symmetrical sweating; (2) Interferes with normal daily activities; (3) Occurs at least once per week; (4) Family history of hyperhidrosis; (5) Does not occur during sleep. Anxiety: (1) Meets the diagnostic criteria for an anxiety disorder; (2) Primarily presents with primary anxiety symptoms and fulfills both of the following conditions: a) Persistent fear or worry over a fixed issue or unspecified matter for a certain period; b) During anxiety episodes there is psychomotor agitation and autonomic dysfunction; (3) The patient subjectively feels unable to endure these symptoms and repeatedly experiences distress; (4) The above criteria have been met for at least 6 months; (5) Excludes anxiety caused by substance abuse or withdrawal from certain drugs; excludes secondary anxiety arising from other mental disorders; excludes anxiety due to stroke cardiovascular diseases or other physical illnesses.

排除标准:

数据缺失较多或不符合诊断标准者排除在外

Exclusion criteria:

Individuals with significant data missing or who do not meet the diagnostic criteria will be excluded.

研究实施时间:

Study execute time:

From 2023-09-12

To      2025-09-12

征募观察对象时间:

Recruiting time:

From 2023-09-12

To      2025-03-05

干预措施:

Interventions:

组别:

焦虑组

样本量:

200

Group:

anxiety group

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

样本总量 Total sample size : 200

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广东省中医院

单位级别:

三甲医院

Institution/hospital:

Guangdong Hospital of Traditional Chinese Medicine

Level of the institution:

3A hospitals

测量指标:

Outcomes:

指标中文名:

焦虑指标

指标类型:

主要指标

Outcome:

Anxiety indicators

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

结束

Completed

年龄范围:

最小 18
Min age years
最大 84
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

none

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用R软件(4.3.1)版本统计软件包进行数据的统计分析处理,其中包括:Lasso回归模型、logistics回归模型、Nomogram图(列线图)、ROC曲线的绘制等显著性水平为α=0.05(当P>0.05时,为无统计学意义;当P<0.05时,为有统计学意义),符合正态分布的计量资料以“均数±标准差”描述,不符合正态分布的计量资料采用中位数(四分位数间距)[M(Q1,Q3)]表示,采用Mann-Whitney U检验。计数资料以n(%)形式表示,组间比较采用独立样本t检验或X2检验。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data were statistically analyzed using R software (version 4.3.1) and its relevant packages including Lasso regression modeling logistic regression modeling nomogram construction and ROC curve plotting. The significance level was set at α = 0.05 (P > 0.05 indicated no statistical significance; P < 0.05 indicated statistical significance). For measurement data that followed a normal distribution the results were expressed as the mean ± standard deviation. For non-normally distributed data results were expressed as the median [interquartile range M(Q1 Q3)] and the Mann-Whitney U test was used. Categorical data were expressed as n(%) and comparisons between groups were made using an independent-samples t-test or a chi-square (χ²) test.

数据管理委员会:

Data Managemen Committee:

No

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above